e-learning
resources
London 2016
Tuesday, 06.09.2016
Biomarkers and phenotypes of COPD and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Role of serum and tissue vascular remodeling markers in bone loss related to end-stage COPD
Evgenia A. Kochetkova (Strasbourg, France), Ludmila G. Ugay, Evgenia A. Kochetkova, Vera A. Nevzorova, Yuliya V. Maistrovskaia
Source:
International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Session:
Biomarkers and phenotypes of COPD and comorbidities
Session type:
Poster Discussion
Number:
4612
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Evgenia A. Kochetkova (Strasbourg, France), Ludmila G. Ugay, Evgenia A. Kochetkova, Vera A. Nevzorova, Yuliya V. Maistrovskaia. Role of serum and tissue vascular remodeling markers in bone loss related to end-stage COPD. Eur Respir J 2016; 48: Suppl. 60, 4612
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Adipokines in end-stage lung diseases: The crosstalk between bone and adipose tissue
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013
Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Molecular mechanisms of lung tissue remodeling in progression of idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010
Biochemical markers of bone remodeling in children with chronic lung diseases
Source: Eur Respir J 2006; 28: Suppl. 50, 262s
Year: 2006
Possible role of liver disease and respiratory insufficiency in osteopenia in cystic fibrosis patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Increased fibrinolytic mediators in IPF as potential contributors to pulmonary fibrosis and vascular remodeling
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Increased levels of glycosaminoglycans in lungs from patients with IPF
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
The effects of tobramycin on pulmonary fibroblast function
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
Chemical exposure triggering connective tissue disease with lung involvement
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015
Markers of pulmonary vascular compromise predict survival in interstitial lung disease (ILD)
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008
Osteoporosis and adipose tissue expression of adipokines and osteoprotegerin in severe chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
¿Idiopathic pulmonary fibrosis or interstitial lung disease associated to connective tissue diseases? Endothelial progenitor cells as a potential tool for the differential diagnosis
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
Inflammatory cell microlocalisation and airway dysfunction: cause and effect?
Source: Eur Respir J 2007; 30: 1043-1056
Year: 2007
Premature aging and skeletal muscle dysfunction in COPD patients: Development of a cell culture model
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
Altered extracellular matrix in transplanted lungs as a potential marker for chronic rejection
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Hepatic function markers in COPD as a systemic implication of the disease
Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates
Year: 2008
The value of biomarkers in the rheumatoid arthritis related interstitial pneumonia
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept